UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000000746
Receipt number R000000897
Scientific Title Phase II study of a combination of TS-1 and TXL for advanced/recurrent gastric cancer patients with peritoneal metastasis
Date of disclosure of the study information 2007/06/29
Last modified on 2009/12/04 17:42:41

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Phase II study of a combination of TS-1 and TXL for advanced/recurrent gastric cancer patients with peritoneal metastasis

Acronym

OGSG0401

Scientific Title

Phase II study of a combination of TS-1 and TXL for advanced/recurrent gastric cancer patients with peritoneal metastasis

Scientific Title:Acronym

OGSG0401

Region

Japan


Condition

Condition

Patients with gastric cancer and peritoneal metastasis

Classification by specialty

Gastroenterology Hematology and clinical oncology Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Effectiveness and adverse events are evaluated on the phase II study of a TS-1 plus Taxol therapy for advanced and/or recurrent gastric cancer.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Overall Survival

Key secondary outcomes

Response Rate
Time To No oral intake
Time To Progression
Adverse Events


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

TXL 50mg/m2 is administered on day 1 and day 8. And TS-1 80 mg/m2 is administered from day 1 to day 14 (14 days). One course is these 14days and subsequent no-treatment 7 days.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1. histologically proven gastric cancer
2. advanced gastric cancer with peritoneal metastasis and/or ascites
1. unresectable due to peritoneal metastasis and/or ascites under X-ray
diagnosis
2. recurrent gastric cancer under diagnosis of biopsy, cytology or X-ray
3. with and without mesurable lesions
4. patient who can take orally ,
5. without any prior chemotherapy or radiation therapy
6. Age: 20-75 yo
7. written informed consent
8. expected survival period longer than 9 weeks
9. Performance status: 0-2 (ECOG criteria)
10. No obvious bone marrow function and sufficient renal/hepatic function a
Hemoglobin 8.0 g/dl <=
WBC: 4,000 /mm3 <= and =< 12,000/mm3
Neutrocyte: 2,000/mm3=<
Platelet: 100,000/mm3 =<
Total bilirubin: 1.5mg/dl =>
GOT, GPT: 100 IU/l =>
Creatinin: within normal range
CRP: 10mg/dl =>

Key exclusion criteria

1.with severe cavity fluid which needs drainage
2.with a central nerve symptoms
3.with fresh intestinal beeding
4.with active double cancers
5.with an allergic reaction against TS-1 or TXL
6.with severe allergy against medicine
7.with severe diseases (cardiac failure, arrhythmia, renal dysfunction, liver dysfunction, interstitial pneumonia, severe neural disorder, uncontrolled DM, intestinal obstruction, etc.)
8.under pregnancy or nursing
9.doctors' decision not to register

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kimura YUtaka

Organization

NTT West Osaka Hospital

Division name

Dpt.Digestive Diseases

Zip code


Address

2-6-40Karasugatuji Tennnouji-Ku Osaka543-8922

TEL

06-6773-7111

Email



Public contact

Name of contact person

1st name
Middle name
Last name Furukawa Hiroshi

Organization

Sakai City Hospital

Division name

Director

Zip code


Address

1-1-1,Minamiyasuicho,Sakai-ku,Sakai, 590-0064

TEL

072-221-1700

Homepage URL


Email

furukawa-h@sakai-hospital.jp


Sponsor or person

Institute

OGSG

Institute

Department

Personal name



Funding Source

Organization

NPO Osaka Chinical Study Supporting Organization

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2007 Year 06 Month 29 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2003 Year 09 Month 16 Day

Date of IRB


Anticipated trial start date

2004 Year 03 Month 01 Day

Last follow-up date

2008 Year 03 Month 01 Day

Date of closure to data entry

2008 Year 10 Month 01 Day

Date trial data considered complete

2008 Year 10 Month 01 Day

Date analysis concluded

2008 Year 10 Month 01 Day


Other

Other related information



Management information

Registered date

2007 Year 06 Month 21 Day

Last modified on

2009 Year 12 Month 04 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000897


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name